Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 ( Mark One ) □ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30 , 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10 - K British Columbia , Canada ( State or other jurisdiction of incorporation or organization ) Title of Each Class Common Stock , no par value For the transition period from Suite 310-815 W Hastings , Vancouver , B.C. , Canada ( Address of principal executive office ) Commission file number : 001-39685 INMED PHARMACEUTICALS INC . ( Exact name of registrant as specified in its charter ) Large accelerated filer Non - accelerated filer to Trading Symbol 82-2726719 ( IRS employer Identification number ) ( 604 ) 669-7207 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Exchange Act : V6C 1B4 ( Zip Code ) Name of Each Exchange On Which Registered The Nasdaq Capital Market INM Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Exchange Act . Yes No Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes > No Indicate by check mark whether the registrant has submitted electronically , every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer " and " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Accelerated filer Smaller reporting company Emerging growth company X If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes No On September 24 , 2021 there were 9,377,034 shares of the registrant's common stock outstanding . DOCUMENTS INCORPORATED BY REFERENCE